Jeffrey B. McGroarty's most recent trade in Annovis Bio Inc was a trade of 28,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 3, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Annovis Bio Inc | Jeffrey B. McGroarty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Jeffrey B. McGroarty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 165,199 | 165,199 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Jeffrey B. McGroarty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 30,396 | 30,396 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Jeffrey B. McGroarty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Jeffrey B. McGroarty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2020 | 300,000 | 300,000 | - | - | Stock Option (right to buy) |